Recombinant PDCD1 (Cetrelimab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-PDCD1 (Cetrelimab Biosimilar) antibody (ABIN7488175) specifically detects PDCD1 (Cetrelimab Biosimilar) in ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN7488175
$323.13
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant PDCD1 (Cetrelimab Biosimilar) antibody (ABIN7488175)
Target
PDCD1 (Cetrelimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This PDCD1 (Cetrelimab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Cetrelimab Biosimilar - Anti-PDCD1, PD1, CD279 mAb
-
Characteristics
- Antibody Type: IgG4-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG4 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- PDCD1 (Cetrelimab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
JNJ-63723283
Cetrelimab (JNJ-63723283) is a Programmed Cell Death Receptor-1 (PD-1) Inhibitor. -
CAS-No
- 2050478-92-5
Target
-
You are here:
